Ferreira Thiago Santos, Lanzetti Manuella, Barroso Marina Valente, Rueff-Barroso Carlos Romualdo, Benjamim Cláudia Farias, de Brito-Gitirana Lycia, Porto Luís Cristóvão, Valença Samuel Santos
Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Inflammation. 2014 Oct;37(5):1355-65. doi: 10.1007/s10753-014-9860-y.
Our aim was to investigate the effects of four different statins on acute lung inflammation induced by cigarette smoke (CS). C57BL/6 male mice were divided into a control group (sham-smoked) and mice exposed to CS from 12 cigarettes/day for 5 days. Mice exposed to CS were grouped and treated with vehicle (i.p.), atorvastatin (10 mg/kg), pravastatin (10 mg/kg), rosuvastatin (5 mg/kg), or simvastatin (20 mg/kg). Treatment with statins differentially improved the pulmonary response when compared to the CS group. Atorvastatin and pravastatin demonstrated slightly effects on inflammation and oxidative stress. Rosuvastatin demonstrated the best anti-inflammatory effect, whereas simvastatin demonstrated the best antioxidant response.
我们的目的是研究四种不同他汀类药物对香烟烟雾(CS)诱导的急性肺部炎症的影响。将C57BL/6雄性小鼠分为对照组(假吸烟)和每天暴露于12支香烟烟雾中持续5天的小鼠组。暴露于CS的小鼠被分组并用载体(腹腔注射)、阿托伐他汀(10mg/kg)、普伐他汀(10mg/kg)、瑞舒伐他汀(5mg/kg)或辛伐他汀(20mg/kg)进行治疗。与CS组相比,他汀类药物治疗对肺部反应有不同程度的改善。阿托伐他汀和普伐他汀对炎症和氧化应激有轻微影响。瑞舒伐他汀表现出最佳的抗炎作用,而辛伐他汀表现出最佳的抗氧化反应。